Long-term in vivo treatment with antioxidants in diabetic Akita mice will be needed to provide evidence whether an association exists between long-term ROS accumulation and the accelerated kinetics of TRPV1 current decay observed in end-stage diabetes. The gene discussed is TRPV1; the disease is diabetes mellitus.